BioCentury
ARTICLE | Financial News

Insys sets range for offering on NASDAQ

April 20, 2013 12:20 AM UTC

Insys Therapeutics Inc. (Pink:NEOL) amended a public offering on NASDAQ and said it now plans list its shares through the sale of 4 million shares at $16-$18. A $17 price would raise $68 million and v...